Diaphragmatic dyskinesia (HDP) and pulmonary function decline
Conditions
Interventions
2ml Group:Ultrasound-guided subparaneural injection of 0.375% ropivacaine (2 mL) at the branch point of the upper trunk of the brachial plexus
5ml Group:Ultrasound-guided subparaneural injection of 0.375% ropivacaine (5 mL) at the branch point of the upper trunk of the brachial plexus
Sponsors
Ningbo Sixth Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) ASA grades I - III (2) Age: 18 - 75 years old (3) BMI: 18 - 30 kg/m²
Exclusion criteria
Exclusion criteria: 1.The patient refuses to participate in the study; 2.Allergy to amide local anesthetics; 3.A history of nerve injury or sensory disturbance in the affected limb on the surgical side; 4.A history of surgery in the shoulder or neck region on the surgical side; 5.Suspected infection in the shoulder or neck region on the surgical side; 6.Complicated with pulmonary diseases (FEV1/FVC 1.5 or platelets 3 months); 9.Complicated with mental, speech, or hearing impairments;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NRS scores;Diaphragmatic excursion; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pulmonary function (FEV1,FVC); | — |
Countries
China
Contacts
Public ContactMiao Zhu
Ningbo Sixth Hospital
Outcome results
None listed